MedTrace Logo

Effect of Free Ticagrelor Fraction on Platelet Membrane Post MI

NCT03658005 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-02-02

No results posted yet for this study

Summary

The purpose of this study is to assess:

* the population pharmacokinetics of unbound ticagrelor and its metabolite in acute coronary syndrome patients treated by ticagrelor
* ticagrelor and its metabolite levels by LC-MS/MS

Conditions

  • Acute Coronary Syndrome

Interventions

OTHER

Blood sample

3 blood samples, for a maximum of 60mL, will be taken at 0-3h, 3-6h and \>6h, between two doses of ticagrelor (taken at 0 and 12 hours).

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Nicolas Meneveau, MD, PhD · Dept of Cardiology, CHU Besancon

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-09
Primary Completion
2022-04-09
Completion
2022-04-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658005 on ClinicalTrials.gov